Canagliflozin is a C-glycosyl compound that functions as an inhibitor of sodium-glucose transport protein subtype 2. It is utilized as a hypoglycemic agent and is employed in pharmaceutical manufacturing for the management of type II diabetes.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Canagliflozin?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Canagliflozin
pharmaceutical raw material
Seladelpar lysine dihydrate
pharmaceutical raw material
Elinzanetant
pharmaceutical raw material
Gadoterate meglumine
pharmaceutical raw material
Guaifenesin
pharmaceutical raw material
[(2R,3R,4R,5S,6S)-3,4,5-triacetyloxy-6-[3-[[5-(4-fluorophenyl)thiophen-2-yl]methyl]-4-methylphenyl]oxan-2-yl]methyl acetate
pharmaceutical raw material
(1S)-1,5-Anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]-D-glucitol 2,3,4,6-tetrakis(2,2-dimethylpropanoate)
research compound
The international HS code for Canagliflozin (CAS 928672-86-0) is 2934.99.
2934.99
2934 99 90
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
(2S,3R,4R,5S,6R)-2-[3-[[5-(4-fluorophenyl)thiophen-2-yl]methyl]-4-methylphenyl]-6-(hydroxymethyl)oxane-3,4,5-triol
XTNGUQKDFGDXSJ-ZXGKGEBGSA-N
CC1=C(C=C(C=C1)[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)CC3=CC=C(S3)C4=CC=C(C=C4)F
Sourcing Canagliflozin?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.